Literature DB >> 16608119

Functions of the HIV-1 matrix protein p17.

Simona Fiorentini1, Elena Marini, Sonia Caracciolo, Arnaldo Caruso.   

Abstract

HIV-1 replication is a dynamic process influenced by a combination of viral and host factors. The HIV-1 matrix protein p17 is a structural protein critically involved in most stages of the life cycle of the retrovirus. It participates in the early stages of virus replication as well as in RNA targeting to the plasma membrane, incorporation of the envelope into virions and particle assembly. Besides its well established functions, p17 acts as a viral cytokine that works on preactivated--but not on resting--human T cells promoting proliferation, proinflammatory cytokines release and HIV-1 replication after binding to a cellular receptor (p17R). Thus, p17 might play a key role in the complex network of host- and virus-derived stimulatory factors contributing to create a favourable environment for HIV-1 infection and replication. Here, we present a brief overview of the functions played by the matrix protein p17 in the HIV-1 life cycle and summarize the current understanding of how p17 could contribute to the pathogenesis of HIV-1 disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16608119

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  29 in total

1.  HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype.

Authors:  Simona Fiorentini; Elena Riboldi; Fabio Facchetti; Manuela Avolio; Marco Fabbri; Giorgio Tosti; Pablo D Becker; Carlos A Guzman; Silvano Sozzani; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-29       Impact factor: 11.205

2.  A New Agent in the Strategy to Cure AIDS.

Authors:  John A Zaia
Journal:  Mol Ther       Date:  2016-11       Impact factor: 11.454

3.  Calmodulin binds a highly extended HIV-1 MA protein that refolds upon its release.

Authors:  James E Taylor; John Y H Chow; Cy M Jeffries; Ann H Kwan; Anthony P Duff; William A Hamilton; Jill Trewhella
Journal:  Biophys J       Date:  2012-08-08       Impact factor: 4.033

Review 4.  Diagnosis and management of lymphomas and other cancers in HIV-infected patients.

Authors:  Antonino Carbone; Emanuela Vaccher; Annunziata Gloghini; Liron Pantanowitz; Akin Abayomi; Paolo de Paoli; Silvia Franceschi
Journal:  Nat Rev Clin Oncol       Date:  2014-03-11       Impact factor: 66.675

5.  Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists.

Authors:  Antonella Bugatti; Cinzia Giagulli; Chiara Urbinati; Francesca Caccuri; Paola Chiodelli; Pasqua Oreste; Simona Fiorentini; Alessandro Orro; Luciano Milanesi; Pasqualina D'Ursi; Arnaldo Caruso; Marco Rusnati
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

6.  Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis.

Authors:  Pietro Mazzuca; Stefania Marsico; Kai Schulze; Stefania Mitola; Marina C Pils; Cinzia Giagulli; Carlos A Guzman; Arnaldo Caruso; Francesca Caccuri
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

Review 7.  HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape.

Authors:  Virginia Carroll; Alfredo Garzino-Demo
Journal:  Pathog Dis       Date:  2015-06-29       Impact factor: 3.166

8.  Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17.

Authors:  Daniele Basta; Olga Latinovic; Mark K Lafferty; Lingling Sun; Joseph Bryant; Wuyuan Lu; Francesca Caccuri; Arnaldo Caruso; Robert Gallo; Alfredo Garzino-Demo
Journal:  Pathog Dis       Date:  2015-09-01       Impact factor: 3.166

9.  Deletions in the fifth alpha helix of HIV-1 matrix block virus release.

Authors:  Bridget Sanford; Yan Li; Connor J Maly; Christian J Madson; Han Chen; You Zhou; Michael Belshan
Journal:  Virology       Date:  2014-09-15       Impact factor: 3.616

10.  Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55Gag with the phospholipase C-delta1 pleckstrin homology domain results in infectious pseudovirion production.

Authors:  Emiko Urano; Toru Aoki; Yuko Futahashi; Tsutomu Murakami; Yuko Morikawa; Naoki Yamamoto; Jun Komano
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.